Ana Berceanu

2.2k total citations
38 papers, 479 citations indexed

About

Ana Berceanu is a scholar working on Hematology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Ana Berceanu has authored 38 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 17 papers in Epidemiology and 13 papers in Infectious Diseases. Recurrent topics in Ana Berceanu's work include Hematopoietic Stem Cell Transplantation (10 papers), Acute Myeloid Leukemia Research (9 papers) and Antifungal resistance and susceptibility (9 papers). Ana Berceanu is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Acute Myeloid Leukemia Research (9 papers) and Antifungal resistance and susceptibility (9 papers). Ana Berceanu collaborates with scholars based in France, United States and Germany. Ana Berceanu's co-authors include Laurence Millon, Anne‐Pauline Bellanger, Steffi Rocchi, Émeline Scherer, Quentin Lepiller, Éric Deconinck, Jean-Christophe Navellou, A. Brion, Flore Sicre de Fontbrune and A. N. Exton‐Smith and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of Clinical Microbiology.

In The Last Decade

Ana Berceanu

33 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ana Berceanu France	11	193	187	135	58	57	38	479
Cécile Fohrer France	10	340 1.8×	313 1.7×	70 0.5×	25 0.4×	103 1.8×	22	528
A. Loy Italy	11	272 1.4×	150 0.8×	123 0.9×	49 0.8×	45 0.8×	21	584
Joann M. McDermid United States	18	178 0.9×	154 0.8×	245 1.8×	75 1.3×	10 0.2×	38	817
P. Pitché Togo	12	76 0.4×	101 0.5×	25 0.2×	58 1.0×	49 0.9×	79	446
Mamta Manglani India	13	162 0.8×	135 0.7×	116 0.9×	43 0.7×	10 0.2×	52	465
Jenna Rossoff United States	8	67 0.3×	113 0.6×	43 0.3×	36 0.6×	68 1.2×	20	283
Jerome Wilson United States	11	155 0.8×	158 0.8×	27 0.2×	40 0.7×	124 2.2×	18	487
Agostino Nocerino Italy	10	302 1.6×	88 0.5×	30 0.2×	46 0.8×	51 0.9×	17	606
Amir Hassan United States	8	83 0.4×	119 0.6×	73 0.5×	34 0.6×	27 0.5×	14	422
Philip A. Pizzo United States	11	214 1.1×	161 0.9×	48 0.4×	40 0.7×	151 2.6×	12	543

Countries citing papers authored by Ana Berceanu

Since Specialization

Citations

This map shows the geographic impact of Ana Berceanu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Berceanu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Berceanu more than expected).

Fields of papers citing papers by Ana Berceanu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Berceanu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Berceanu. The network helps show where Ana Berceanu may publish in the future.

Co-authorship network of co-authors of Ana Berceanu

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Berceanu. A scholar is included among the top collaborators of Ana Berceanu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Berceanu. Ana Berceanu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Forcade, Édouard, Marie Robin, Marie‐Thérèse Rubio, et al.. (2024). IDALLO study: A retrospective multicenter study of the SFGM‐TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1‐mutated AML after allogeneic hematopoietic cell transplantation. HemaSphere. 8(3). e44–e44.

Vauchy, Charline, Éric Deconinck, Ana Berceanu, et al.. (2024). Kidney Transplantation After Allogeneic Hematopoietic Cell Transplantation. Kidney International Reports. 9(4). 1127–1131. 2 indexed citations

Xhaard, Aliénor, Constance Xhaard, Marie‐Thérèse Rubio, et al.. (2023). A 16‐month‐long experience of COVID‐19 in allogeneic haematopoietic stem cell transplantation recipients: An SFGM‐TC multicentre cohort study. British Journal of Haematology. 201(6). 1066–1071. 3 indexed citations

Berceanu, Ana, et al.. (2023). Human cytomegalovirus-viruria in hematopoietic stem cell transplant recipients: Context and impact. Infectious Diseases Now. 53(3). 104651–104651.

Bellanger, Anne‐Pauline, Étienne Daguindau, Steffi Rocchi, et al.. (2022). Refractory invasive pulmonary aspergillosis due to Aspergillus flavus detected with the combination of two in-house Aspergillus qPCR. Journal de Mycologie Médicale. 33(1). 101350–101350. 2 indexed citations

Labopin, Myriam, Sebastian Giebel, Thomas Schroeder, et al.. (2022). Total body irradiation plus fludarabine versus busulfan plus fludarabine as a myeloablative conditioning for adults with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study on behalf of the Acute Leukemia Working Party of the EBMT. Bone Marrow Transplantation. 58(3). 282–287. 1 indexed citations

Bellanger, Anne‐Pauline, Jean-Christophe Navellou, Quentin Lepiller, et al.. (2021). Mixed mold infection with Aspergillus fumigatus and Rhizopus microsporus in a severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) patient. Infectious Diseases Now. 51(7). 633–635. 56 indexed citations

Pierron, Alix, Ana Berceanu, Jean Fontan, et al.. (2021). Vaccination coverage in hematological patients undergoing chemotherapy: Should we move towards personalized vaccination?. Vaccine. 39(48). 7036–7043. 5 indexed citations

Giebel, Sebastian, Myriam Labopin, Gèrard Socié, et al.. (2020). Allogeneic HCT for adults with B-cell precursor acute lymphoblastic leukemia harboring IKZF1 gene mutations. A study by the Acute Leukemia Working Party of the EBMT. Bone Marrow Transplantation. 56(5). 1047–1055. 1 indexed citations

10.

Robin, Christine, Anne Thiébaut, Sophie Alain, et al.. (2020). Letermovir for Secondary Prophylaxis of Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Cell Transplantation: Results from the French Compassionate Program. Biology of Blood and Marrow Transplantation. 26(5). 978–984. 54 indexed citations

11.

Bazarbachi, Ali, Myriam Labopin, Didier Blaise, et al.. (2020). Comparable outcomes of haploidentical transplant with TBF conditioning versus matched unrelated donor with fludarabine/busulfan conditioning for acute myeloid leukemia. Bone Marrow Transplantation. 56(3). 622–634. 6 indexed citations

12.

Roussel, Xavier, Étienne Daguindau, Ana Berceanu, et al.. (2020). Acute Myeloid Leukemia: From Biology to Clinical Practices Through Development and Pre-Clinical Therapeutics. Frontiers in Oncology. 10. 599933–599933. 16 indexed citations

13.

Bellanger, Anne‐Pauline, Steffi Rocchi, Ana Berceanu, et al.. (2020). Positive quantitative PCR detecting Fusarium solani in a case of mixed invasive fungal disease due to Mucorales and Fusarium solani. Bone Marrow Transplantation. 55(5). 873–876. 5 indexed citations

14.

Roussel, Xavier, Étienne Daguindau, Ana Berceanu, et al.. (2019). Altered thymic CD4+ T-cell recovery after allogeneic hematopoietic stem cell transplantation is critical for nocardiosis. Current Research in Translational Medicine. 67(4). 135–143. 4 indexed citations

15.

Prata, Pedro Henrique, Matthieu Resche‐Rigon, Didier Blaise, et al.. (2019). Outcomes of Salvage Haploidentical Transplant with Post-Transplant Cyclophosphamide for Rescuing Graft Failure Patients: a Report on Behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy. Biology of Blood and Marrow Transplantation. 25(9). 1798–1802. 17 indexed citations

16.

Bellanger, Anne‐Pauline, et al.. (2018). Local retrospective analysis of galactomannan cut-off values in bronchoalveolar lavage fluids for diagnosis of invasive aspergillosis. Folia Microbiologica. 63(6). 757–761. 2 indexed citations

17.

Bellanger, Anne‐Pauline, Ana Berceanu, Steffi Rocchi, et al.. (2018). Development of a quantitative PCR detecting Cunninghamella bertholletiae to help in diagnosing this rare and aggressive mucormycosis. Bone Marrow Transplantation. 53(9). 1180–1183. 15 indexed citations

18.

Bellanger, Anne‐Pauline, Laurence Millon, Ana Berceanu, et al.. (2015). CombiningAspergillusmitochondrial and ribosomal QPCR, in addition to galactomannan assay, for early diagnosis of invasive aspergillosis in hematology patients. Medical Mycology. 53(7). 760–764. 15 indexed citations

19.

Guillaume, Thierry, Ana Berceanu, A Charbonnier, et al.. (2014). Recommandations de la SFGM-TC concernant l’injection prophylactique, préemptive et curative des lymphocytes du donneur (DLI) après allogreffe de cellules souches hématopoïétiques. Pathologie Biologie. 62(4). 193–196. 11 indexed citations

20.

Berceanu, Ana, Stéphane Leprêtre, Mario Ojeda‐Uribe, et al.. (2011). Prophylaxie antibactérienne et antifongique chez les patients à haut risque en hématologie Enquête de pratique et forum. Hématologie. 17(4). 3–15. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact